“…The trimer-binding interface between individual S protomers and the interaction sites of trimerization are not fully characterized for the SARS-CoV-2. Recent studies have suggested several residues that contribute to the formation or to stabilize the S trimeric structure; and most of them are located at the S2 subunit (mainly in the S2-NTD, FP, CR, HR1, CH and CD) [53] , [54] , [55] , [56] , [57] , [58] . Thirteen of these residues (E702, Y707, N709, N710, Y789, K790, K795, F797, G798, T859, G891, Q895, F898) are described by multiple authors and represent CDR or T-RHS for drug targeting highlighted in our study [53] , [54] , [55] , [56] , [57] , [58] .…”